KPL-404
KPL-404-C211
Phase 2 small_molecule completed
Quick answer
KPL-404 for Arthritis, Rheumatoid is a Phase 2 program (small_molecule) at Kiniksa Pharmaceuticals International, plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kiniksa Pharmaceuticals International, plc
- Indication
- Arthritis, Rheumatoid
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed